| # | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. |  ALA429910 | 6, dapagliflozin | Ratio EC50 | = | 247.1 | ALA2065403 | ||||||
| 2. | ALA429910 | 6, dapagliflozin | EC50 | = | 593 | nM | ALA2065402 | 6.23 | nM | Homo sapiens | ||
| 3. | ALA429910 | 6, dapagliflozin | EC50 | = | 2.4 | nM | ALA2065401 | 8.62 | nM | Homo sapiens | ||
| 4. | ALA429910 | 6, dapagliflozin | Ratio IC50 | 0 | ALA2051190 | Not Determined | Homo sapiens | |||||
| 5. | ALA429910 | 6, dapagliflozin | IC50 | 0 | ALA2051080 | Not Determined | Homo sapiens | |||||
| 6. | ALA429910 | 6, dapagliflozin | IC50 | 0 | ALA2051079 | Not Determined | Homo sapiens | |||||
| 7. | ALA429910 | 6, dapagliflozin | Ratio IC50 | = | 620 | ALA2051078 | ||||||
| 8. | ALA429910 | 6, dapagliflozin | IC50 | = | 800 | nM | ALA2051077 | 6.10 | nM | Homo sapiens | ||
| 9. | ALA429910 | 6, dapagliflozin | IC50 | = | 1.3 | nM | ALA2051076 | 8.89 | nM | Homo sapiens | ||
| 10. | ALA429910 | 6, dapagliflozin | IC50 | = | 1 | nM | ALA3292468 | 9.00 | nM | Homo sapiens | ||
| 11. | ALA429910 | 6, dapagliflozin | IC50 | = | 891 | nM | ALA3292469 | 6.05 | nM | Homo sapiens | ||
| 12. | ALA429910 | 6, dapagliflozin | IC50 | = | 5 | nM | ALA3406875 | 8.30 | nM | Homo sapiens | ||
| 13. | ALA429910 | 6, dapagliflozin | inhibition | = | 0.11 | % | ALA4513082 | % | Severe acute respiratory syndrome coronavirus 2 | |||
| 14. | ALA429910 | 6, dapagliflozin | inhibition | = | -0.14 | % | ALA4513082 | % | Severe acute respiratory syndrome coronavirus 2 | |||
| 15. | ALA429910 | 6, dapagliflozin | Inhibition | = | 13.811 | % | ALA4495582 | % | Severe acute respiratory syndrome coronavirus 2 | |||
| 16. | ALA429910 | 6, dapagliflozin | Inhibition | = | 11.09 | % | ALA4495582 | % | Severe acute respiratory syndrome coronavirus 2 | |||
| 17. | ALA429910 | 6, dapagliflozin | pIC50 | < | 4.7 | ALA4651403 | No. Measurements = 1 | nM | Severe acute respiratory syndrome coronavirus 2 | |||
| 18. | ALA429910 | 6, dapagliflozin | IC50 | > | 0 | M | ALA4651403 | No. Measurements = 1 | nM | Severe acute respiratory syndrome coronavirus 2 | ||
| 19. | ALA429910 | 6, dapagliflozin | inhibition | = | -0.14 | % | ALA4513082 | % | Severe acute respiratory syndrome coronavirus 2 | |||
| 20. | ALA429910 | 6, dapagliflozin | inhibition | = | 0.11 | % | ALA4513082 | % | Severe acute respiratory syndrome coronavirus 2 |
The page will load shortly, Thanks for your patience!